Woodline Partners LP Decibel Therapeutics, Inc. Transaction History

Woodline Partners LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.85 - $4.21 $508,751 - $1.16 Million	-275,001 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$4.57 - $8.58 $25,007 - $46,949	-5,472 Reduced 1.95%	275,001 $1.28 Million
Q3 2021 Nov 15, 2021	SELL	$6.6 - $9.04 $250 - $343	-38 Reduced 0.01%	280,473 $2.16 Million
Q1 2021 May 17, 2021	BUY	$10.56 - $19.9 $2.96 Million - $5.58 Million	280,511 New	280,511 $3.19 Million

Ticker DBTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,964,500
Description
Decibel Therapeutics, Inc., a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. Its product candidates and programs focuses on three areas, such as Gene Therapies for Congenital, Monogenic Hearing Loss designed to restore functional cells within the cochlea to...

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

Stay updated on Woodline Partners LP with notifications on news.